Literature DB >> 11105427

Celiac disease--a worldwide problem.

K Horvath1, D I Mehta.   

Abstract

Celiac disease and dermatitis herpetiformis are caused by the alcohol soluble fractions of wheat, barley, and rye. Reliable serological tests are available for both mass and risk group screening and recent epidemiological studies on celiac disease suggest that the prevalence varies between 1:100-300 in different continents. The clinical manifestations of the disease has changed in the West and the classical symptomatic cases represent only approximately 1/7th of all diagnosed cases. Symptoms such as, anemia, short stature, dental enamel defect or osteoporosis can be the only manifestations of the atypical disease. There is an increased prevalence of celiac disease in patients with autoimmune diseases. Recent data suggest that there is a correlation between the prevalence of autoimmune diseases and the number of years that an individual consumes gluten-containing foods. Genetic studies revealed a high prevalence of certain HLA antigens in celiac patients, however, there is likelihood that non-HIA genes are also important in the pathomechanism. An interesting new development is the recognition of tissue transglutaminase (tTG), an enzyme that probably forms an autoantigen with gluten. It is generally accepted that antibodies to tTG are identical to the previously described antiendomysium antibodies. Whether or not tTG is responsible for the initiation of an immunoreaction against prolamines or just exacerbates the immune response is a subject of further investigations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11105427     DOI: 10.1007/bf02723936

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  39 in total

1.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

2.  Specific high-affinity binding sites for a synthetic gliadin heptapeptide on human peripheral blood lymphocytes.

Authors:  D G Payan; K Horváth; L Gráf
Journal:  Life Sci       Date:  1987-03-23       Impact factor: 5.037

Review 3.  HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis.

Authors:  L M Sollid; E Thorsby
Journal:  Gastroenterology       Date:  1993-09       Impact factor: 22.682

4.  Prevalence of coeliac disease in diabetic children and their first- degree relatives in west Algeria: screening with serological markers.

Authors:  G Boudraa; W Hachelaf; M Benbouabdellah; M Belkadi; F Z Benmansour; M Touhami
Journal:  Acta Paediatr Suppl       Date:  1996-05

5.  Naloxone antagonises effect of alpha-gliadin on leucocyte migration in patients with coeliac disease.

Authors:  K Horváth; L Gráf; E Walcz; H Bodánszky; D Schuler
Journal:  Lancet       Date:  1985-07-27       Impact factor: 79.321

6.  IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease.

Authors:  T P Chorzelski; E H Beutner; J Sulej; H Tchorzewska; S Jablonska; V Kumar; A Kapuscinska
Journal:  Br J Dermatol       Date:  1984-10       Impact factor: 9.302

7.  Elevated serum aminotransferase activity as an early manifestation of gluten-sensitive enteropathy.

Authors:  P Vajro; A Fontanella; M Mayer; A De Vincenzo; L M Terracciano; M D'Armiento; R Vecchione
Journal:  J Pediatr       Date:  1993-03       Impact factor: 4.406

8.  Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge.

Authors:  M Kontakou; R T Przemioslo; R P Sturgess; G A Limb; H J Ellis; P Day; P J Ciclitira
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

9.  Coeliac disease in Sudanese children.

Authors:  G I Suliman
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

10.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  1 in total

1.  Hypogalactosylation of serum IgG in patients with coeliac disease.

Authors:  J A Cremata; L Sorell; R Montesino; R Garcia; M Mata; G Cabrera; J A Galvan; G Garcia; R Valdes; J A Garrote
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.